ArticleGenes & diseases2024

Colony-stimulating factor-1 receptor inhibition combined with paclitaxel exerts effective antitumor effects in the treatment of ovarian cancer.

Meijia Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.